Savanah Petroleum (SAVP) first detailed the highly complex Seven Energy deal in a 503 page prospectus back in December 2017. I saw this deal as negative for all the reasons related to timescale and risk I set out recently, but good if it completed. The deal changed in December 2018 and now I am not so sure it is good!

A month or so ago, I noted that Reckitt Benckiser (RB.) was a 'lower £60s buy in anticipation of a share price beginning with a '7' plus some solid dividend wrap-around...and a call option on that full split potential'. The rationale for this was not just the company's range of top products (Vanish, Nurofen, Dettol, Durex, etc.) nor even just potential upcoming split or a recently announced management evolution which I think is overdue. It was also centred on the likely resolution of the company's legacy problems with its ex pharmaceutical unit Indivior (INDV)...

Lib Dem grandee Lord Timmy Razzall may have changed the name of Boxhill to St James House (SJH) but this company which has been mired in so much corruption and fraud remains an uninvestable uber dog even by the standards of  the AIM casino. Results earlier this week were covered in bearcast yesterday but perhaps merit further scrutiny. They are shocking, breach IFRS on numerous counts and quite simply aim to decieve. Nomad Allenby should be walking.

AIM-listed Sosandar (SOS) has announced a £7 million placing at 15p – a small premium to yesterday’s close. The small premium is good news – or would be but the shares were over 20p just a couple of weeks back….and then came the results and trading update.

I reviewed PetroTal Corp (PTAL) only a few weeks ago, concluding I could see a positive investment case, but noted keeping a close eye on progress would needed. The update today confirms production levels, but I was not expecting social unrest to have an adverse impact.

Tom writes: The bottom line is that I shall be selling the FIML shares but am giving you at least 24 hours notice. This is NOT a financial call but an ethical call, as I explain, and Steve Moore, who will cover Yourgene going forward, explains why he is not selling his shares on the results and where he sees them going...

After a few torrid days, Neil Woodford’s Income Focus Fund managed to put on 0.33% in NAV per unit yesterday, according to this morning’s data from Morningstar. With the fund having dropped to £286.3 million on Tuesday, that should have seen it up to £287.2 million before redemptions.

“Further to the board's announcement of 7 June 2019, Modern Water (MWG), the owner of world-leading technologies for water and wastewater treatment and for water quality monitoring, announces a further update in relation to its funding discussions and working capital position”. Hmmm – “world-leading technologies” hey, but that previous update including “cash flows have been slower than anticipated from the Membranes Division and, consequently, additional working capital will be required in the short-term” and now another intra-day (this one 3:31pm) update?!...

Provider of digital media and technology, Catenae Innovation (CTEA) has announced results for its half year ended 31^st March 2019 and that “the company is now in a position where it is taking advantage of the existing product suite and is seeing growth in terms of potential pipeline and converted sales. The company continues to look at opportunities that enable it to expand its reach into new sectors and to significantly increase its growth”…

Hello, Share Toasters. It must be ten years ago now that I dumped my shares in Wood Group (WG.), the supplier of stuff and services to the black gold industry among other related functions, including greener forms of energy. I didn't regret that move as the share price hit a chequered path afterwards, suffering like all oil-related companies from the infamous oil price crash...

Previously updating in early May, “data science led agency and consulting business” Jaywing (JWNG) noted “a year of solid progress… We have seen encouraging growth in Epiphany, our online performance marketing division, and also in our fast-growing operations in Australia… Jaywing will announce its preliminary results for the year ended 31st March 2019 in July” but also “ongoing challenging market conditions within the UK and continued uncertainty surrounding its anticipated withdrawal from the European Union”. Now a further “Trading Statement” – and at an intra-day 11:37am. Uh oh…

I start with a few notes on  tomorrow, logistics and the funeral of Uncle Chris Booker. Then it is onto Yourgene (YGEN), Thomas Cook (TCG), Advanced Oncotherapy (AVO), Amur Minerals (AMC), and the dog St James House (SJH) formerly known as the Boxhill hound.

Finally the research powerhouse that is Stifel has initiated its coverage of its corporate client Yourgene (YGEN) with a detailed note which is below. A senior officer at Yourgene supplied the note to me. In the past on every occassion this has happened. On this occassion Stifel has demanded that I withdraw the note and pay it £750 or it will throw the book at me. I have taken the note down. If it wants the £750 it can ask Yourgene directly. What is the point, I wonder, of hiring a big name broker to produce research and then trying to reduce the number of folks who read that research? Whatever.

AIM-listed Redx Pharma (REDX) has released great news in that it has sold one of its products for $3.5 million upfront plus up to $203 million in milestone and royalty payments, plus a cut of any sales. That’s a lot of cash – or it may be, if all the hurdles are passed successfully – but of course, those hurdles may not be quite so easy to clear, and it certainly won’t be any time soon. The shares are up heavily by 124% at 14p on the news, but I just wonder if the market is suffering from over-enthusiasm.

Lots of interesting numbers out today but let me concentrate on two. First, recruiter PageGroup (PAGE) has a share price shocker (down 14% at the time of writing) after apparently enjoying 'a record quarter'…

The silly campaign by whining remoaners to boycott JD Wetherspoon (JDW) is not working. Ha! For the 10 weeks to 7 July 2019 like-for-like sales increased by 6.9% and total sales increased by 6.6%. Year-to-date like-for-like sales have increased by 6.7% and total sales increased by 7.4%.. In bringing us this good news, chairman Tim Martin is again our hero of the day for some sane words on Brexit Tired of Project Fear from the BBC, the Quislings at the CBI, The Guardian, the pink comic that is the FT and our own Malcolm Stacey?  Over to Tim who writes:

Kier Group (KIE) fell a further 10% yesterday. Given that it was the fifth largest holding in Neil Woodford’s Income Focus Fund (WIFF) – despite offering no income – at the end of May, that’s not a good start and according to Morningstar the fund dropped 0.8% in terms of NAV per share.

Boatman Capital has been the scourge of Babcock (BAB) but now shows it is not a one trick pony. Its next target is AVZ Minerals. It is Oz listed but the report is a fascinating insight into the seedy world of mining. We thus bring it to you in full below.

Vela Technologies (VELA) has noted an announcement by BlockchainK2 Corp (TSXV - BITK) in which it currently has 272,000 shares; a 1.81% stake…

Hello, Share Campers. When supply falls short of demand, or even likely demand, the happy supplier should be able to keep prices high and still make a tasty profit. That should go without saying. But those who criticise my current support for housebuilders rarely take into consideration this basic rule of o-level economics...